Adipogenesis and WNT signalling

Trends in Endocrinology and Metabolism

Volumn 20, Issue 1, 2009, Pages 16-24

  Christodoulides, Constantinos ^a,b   Lagathu, Claire ^a   Sethi, Jaswinder K ^a   Vidal Puig, Antonio ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE CELL; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL FATE; CELL GROWTH; DISEASE PREDISPOSITION; HUMAN; INSULIN RESISTANCE; MESENCHYMAL STEM CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE EXPANSION; WHITE ADIPOSE TISSUE;

ADIPOGENESIS; ANIMALS; BETA CATENIN; ENERGY METABOLISM; HUMANS; INFLAMMATION MEDIATORS; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; OBESITY; PPAR GAMMA; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 58149252268     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.09.002     Document Type: Review

References (62)

1. Kahn B.B., and Flier J.S. Obesity and insulin resistance. J. Clin. Invest. 106 (2000) 473-481
2. Sethi J.K., and Vidal-Puig A.J. Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J. Lipid Res. 48 (2007) 1253-1262
3. Gray S.L., and Vidal-Puig A.J. Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr. Rev. 65 (2007) S7-S12
4. Savage D.B., et al. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45 (2005) 828-833
5. Rosen E.D., and Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 (2006) 847-853
6. Montague C.T., and O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49 (2000) 883-888
7. Spalding K.L., et al. Dynamics of fat cell turnover in humans. Nature 453 (2008) 783-787
8. Rosen E.D., and MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7 (2006) 885-896
9. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab. 4 (2006) 263-273
10. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20 (2004) 781-810
11. Taipale J., and Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature 411 (2001) 349-354
12. Semenov M.V., et al. SnapShot: noncanonical Wnt signaling pathways. Cell 131 (2007) 1378
13. Mikels A.J., and Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene 25 (2006) 7461-7468
14. Jones S.E., and Jomary C. Secreted frizzled-related proteins: searching for relationships and patterns. Bioessays 24 (2002) 811-820
15. Kawano Y., and Kypta R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116 (2003) 2627-2634
16. Ross S.E., et al. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
17. Bennett C.N., et al. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277 (2002) 30998-31004
18. Krishnan V., et al. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116 (2006) 1202-1209
19. Longo K.A., et al. Wnt10b inhibits development of white and brown adipose tissues. J. Biol. Chem. 279 (2004) 35503-35509
20. Wright W.S., et al. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 56 (2007) 295-303
21. Bennett C.N., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3324-3329
22. Kang S., et al. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein α and peroxisome proliferator-activated receptor γ. J. Biol. Chem. 282 (2007) 14515-14524
23. Bodine P.V., et al. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol. Endocrinol. 18 (2004) 1222-1237
24. Koza R.A., et al. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet. 2 (2006) e81
25. Vertino A.M., et al. Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol. Biol. Cell 16 (2005) 2039-2048
26. Arango N.A., et al. Conditional deletion of β-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev. Biol. 288 (2005) 276-283
27. Garcia-Gras E., et al. Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J. Clin. Invest. 116 (2006) 2012-2021
28. Lagathu C., et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem. Biophys. Res. Commun. 311 (2003) 372-379
29. Cawthorn W.P., and Sethi J.K. TNF-α and adipocyte biology. FEBS Lett. 582 (2008) 117-131
30. Gustafson B., and Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J. Biol. Chem. 281 (2006) 9507-9516
31. Cawthorn W.P., et al. Tumour necrosis factor-α inhibits adipogenesis via a β-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ. 14 (2007) 1361-1373
32. Waki H., et al. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARγ expression. Cell Metab. 5 (2007) 357-370
33. Liu J., and Farmer S.R. Regulating the balance between peroxisome proliferator-activated receptor γ and β-catenin signaling during adipogenesis. A glycogen synthase kinase 3β phosphorylation-defective mutant of β-catenin inhibits expression of a subset of adipogenic genes. J. Biol. Chem. 279 (2004) 45020-45027
34. Liu J., et al. Functional interaction between peroxisome proliferator-activated receptor γ and β-catenin. Mol. Cell. Biol. 26 (2006) 5827-5837
35. Moldes M., et al. Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis. Biochem. J. 376 (2003) 607-613
36. Kennell J.A., et al. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with β-catenin to coactivate C/EBPα and steroidogenic factor 1 transcription factors. Mol. Cell. Biol. 23 (2003) 5366-5375
37. Takemaru K., et al. Chibby, a nuclear β-catenin-associated antagonist of the Wnt/Wingless pathway. Nature 422 (2003) 905-909
38. Li F.Q., et al. Chibby promotes adipocyte differentiation through inhibition of β-catenin signaling. Mol. Cell. Biol. 27 (2007) 4347-4354
39. Topol L., et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation. J. Cell Biol. 162 (2003) 899-908
40. Westfall T.A., et al. Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/β-catenin activity. J. Cell Biol. 162 (2003) 889-898
41. Mikels A.J., and Nusse R. Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol. 4 (2006) e115
42. Kanazawa A., et al. Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes. Am. J. Hum. Genet. 75 (2004) 832-843
43. Kanazawa A., et al. Wnt5b partially inhibits canonical Wnt/β-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 330 (2005) 505-510
44. Takada I., et al. A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-γ transactivation. Nat. Cell Biol. 9 (2007) 1273-1285
45. Kennell J.A., and MacDougald O.A. Wnt signaling inhibits adipogenesis through β-catenin-dependent and -independent mechanisms. J. Biol. Chem. 280 (2005) 24004-24010
46. Kang S., et al. Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1α. Mol. Cell. Biol. 25 (2005) 1272-1282
47. Tseng Y.H., et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat. Cell Biol. 7 (2005) 601-611
48. Tseng Y.H., et al. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol. Cell. Biol. 24 (2004) 1918-1929
49. Christodoulides C., et al. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J. Cell Sci. 119 (2006) 2613-2620
50. Ai M., et al. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling. Mol. Cell. Biol. 25 (2005) 4946-4955
51. Qiu W., et al. Patients with high bone mass phenotype exhibit enhanced osteoblast differentiation and inhibition of adipogenesis of human mesenchymal stem cells. J. Bone Miner. Res. 22 (2007) 1720-1731
52. Kumar S., et al. Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis. J. Clin. Endocrinol. Metab. 90 (2005) 4730-4735
53. Gesta S., et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6676-6681
54. Christodoulides C., et al. WNT10B mutations in human obesity. Diabetologia 49 (2006) 678-684
55. Karelis A.D., et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab. 89 (2004) 2569-2575
56. Ruderman N., et al. The metabolically obese, normal-weight individual revisited. Diabetes 47 (1998) 699-713
57. Agarwal A.K., and Garg A. Genetic basis of lipodystrophies and management of metabolic complications. Annu. Rev. Med. 57 (2006) 297-311
58. Klein S., et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N. Engl. J. Med. 350 (2004) 2549-2557
59. Yki-Jarvinen H. Thiazolidinediones. N. Engl. J. Med 351 (2004) 1106-1118
60. Tran T.T., et al. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7 (2008) 410-420
61. Kim J.Y., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117 (2007) 2621-2637
62. Medina-Gomez G., et al. PPAR γ 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 3 (2007) e64